Furthermore, the 27 overlapping ASEs were analyzed in a siESRP1 RNA-Seq experiment in endocrine-resistant BC cell lines (2C3, 9C3 from [17]), showing 14 ASEs (63.6%) were significantly (p < 0.05) regulated upon ESRP1 silencing (Figure 5b and Supplementary Materials Table S8e). The gene discussed is ESRP1; the disease is breast cancer.